154 related articles for article (PubMed ID: 16634690)
1. The treatment of urinary tract infections and use of ciprofloxacin extended release.
Hickerson AD; Carson CC
Expert Opin Investig Drugs; 2006 May; 15(5):519-32. PubMed ID: 16634690
[TBL] [Abstract][Full Text] [Related]
2. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
Talan DA; Naber KG; Palou J; Elkharrat D
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
[TBL] [Abstract][Full Text] [Related]
3. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
Blondeau JM
Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
[TBL] [Abstract][Full Text] [Related]
4. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.
Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N
Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
Waugh J; Keating GM
Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044
[TBL] [Abstract][Full Text] [Related]
7. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.
Carson C; Naber KG
Drugs; 2004; 64(12):1359-73. PubMed ID: 15200349
[TBL] [Abstract][Full Text] [Related]
8. The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009.
Cullen IM; Manecksha RP; McCullagh E; Ahmad S; O'Kelly F; Flynn RJ; McDermott T; Murphy P; Grainger R; Fennell JP; Thornhill JA
BJU Int; 2012 Apr; 109(8):1198-206. PubMed ID: 21883861
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
10. The expanding role of fluoroquinolones.
Schaeffer AJ
Am J Med; 2002 Jul; 113 Suppl 1A():45S-54S. PubMed ID: 12113871
[TBL] [Abstract][Full Text] [Related]
11. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
[TBL] [Abstract][Full Text] [Related]
12. The expanding role of fluoroquinolones.
Schaeffer AJ
Dis Mon; 2003 Feb; 49(2):129-47. PubMed ID: 12601342
[TBL] [Abstract][Full Text] [Related]
13. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance.
Miller LG; Tang AW
Mayo Clin Proc; 2004 Aug; 79(8):1048-53; quiz 1053-4. PubMed ID: 15301333
[TBL] [Abstract][Full Text] [Related]
14. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
Klimberg I; Shockey G; Ellison H; Fuller-Jonap F; Colgan R; Song J; Keating K; Cyrus P
Curr Med Res Opin; 2005 Aug; 21(8):1241-50. PubMed ID: 16083534
[TBL] [Abstract][Full Text] [Related]
15. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
[TBL] [Abstract][Full Text] [Related]
16. Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation.
Wojciechowski D; Chandran S
Transplantation; 2013 Aug; 96(4):400-5. PubMed ID: 23698597
[TBL] [Abstract][Full Text] [Related]
17. Resistance Patterns of Escherichia coli in Women with Uncomplicated Urinary Tract Infection Do Not Correlate with Emergency Department Antibiogram.
Hines MC; Al-Salamah T; Heil EL; Mallemat H; Witting MD; Johnson JK; Winters ME; Hayes BD
J Emerg Med; 2015 Dec; 49(6):998-1003. PubMed ID: 26281821
[TBL] [Abstract][Full Text] [Related]
18. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.
Beerepoot MA; ter Riet G; Nys S; van der Wal WM; de Borgie CA; de Reijke TM; Prins JM; Koeijers J; Verbon A; Stobberingh E; Geerlings SE
Arch Intern Med; 2011 Jul; 171(14):1270-8. PubMed ID: 21788542
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
[TBL] [Abstract][Full Text] [Related]
20. Tackling antimicrobial resistance in lower urinary tract infections: treatment options.
Pitout JD; Chan WW; Church DL
Expert Rev Anti Infect Ther; 2016 Jul; 14(7):621-32. PubMed ID: 27177113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
